Replies to post #31201 on Revive Therapeutics Ltd (RVVTF)

[Prominent Capital]

They are missing deadlines all time. No one knows how we will be wait here. I think MF need to take his role more serious and stop smoking cigar and giving interviews at the way.

[2014shelby]

What else can be done aside from offering additional $ for participation?

[alabama1man]

whether US or Turkey, unless some serious enrollment starts occurring in the next 2 weeks, there's no way they can complete the trial in Q2. They would need to get approx 85 (assuming the 715 number that we last heard is still the current number) by mid-May to get to 800 in Q2 and have the data reviewed (by DSMB?) to get a recommendation whether to unblind / submit. That's looking at the timeline of needing at least 8 days to get the subject through the dosing / evaluation.

[rickstereo3333]

Where is all this extra cash to pay patients and speed up enrollment is supposed to come from exactly?

The screening of patients based on the criteria listed looks to be time consuming and very costly.

Its not like Revive has started generating any revs yet.

Last I checked they have already burned through ~$21M in the last year, the majority of which has been for the trial....there are many other expenses to be paid and cash is limited imo.

I get that people are impatient but the fact remains we are not connected like the pfizers and modernas, meaning we dont get a pass.

We already that covid will be with us for a very long time in ever changing forms and as such time is not the "killshot" issue its being made out to be....just yet.

The other pills from pfizer and merck are not scalable yet and theyre not for general use as Bucil will be if its granted eua.

At this point the only thing that really matters is that its found to be effective, not how long the trial is taking.

AIMOOC